Roche Dx Inks Manufacturing Deal with Ionian for Nucleic Acid Amplification Tech

Under the terms of the agreement, Roche "will identify new applications and customers" for Ionian's NEAR technology and will have exclusive manufacturing rights for any commercialization opportunities that arise from the collaboration.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.